```markdown
A_First_Name: Akshay
A_Last_Name: Chaudhari
A_DOB: 02/17/1987
A_Address: 1460 El Camino Real
A_City: Arlington
A_State: VA
A_ZIP: 22407
A_Home_Phone: 570-599-6973
A_Work_Phone:
A_Cell_Phone:
A_Email:
A_Weight: 190 lbs
A_Height: 73 in
A_Allergies: None

B_Aetna_Member_ID: 350410732018
B_Other_Coverage: No
B_Group_Number:
B_Other_ID:
B_Carrier_Name: Aetna Better Health of Virginia
B_Insured_Relation: Self
B_Medicare: No
B_Medicare_ID:
B_Medicaid: No
B_Medicaid_ID:

C_Prescriber_First_Name: Timothy
C_Prescriber_Last_Name: Adam
C_Prescriber_Type: M.D.
C_Prescriber_Address: 2755 College Ave Ste. 100
C_Prescriber_City: Leesburg
C_Prescriber_State: VA
C_Prescriber_ZIP: 20176
C_Prescriber_Phone: 203-818-3060
C_Prescriber_Fax: 203-818-3061
C_Prescriber_State_License:
C_NPI: 1321124163
C_DEA:
C_UPIN:
C_Email: intake@thealth.com
C_Office_Contact:
C_Office_Phone: 203-818-3060
C_Specialty: Gastroenterologist

D_Place_of_Administration: Outpatient Infusion Center
D_Patient_Selected: Outpatient Infusion Center
D_Center_Name:
D_Center_Phone:
D_Center_Address:
D_TIN:
D_PIN:
D_CPT:

E_Product: Skyrizi (risankizumab-rzaa)
E_Dose: 600 mg IV at weeks 0, 4, 8; 360 mg SQ at week 12 and every 8 weeks
E_Frequency: per protocol

F_Primary_ICD: K50.111
F_Secondary_ICD:
F_Other_ICD:

G_Combination_Other_Biologic: No
G_Ever_Received_Biologic_Targeted: Yes
G_TB_Test_Within_6mo: Yes
G_TB_Test_Type: interferon-release assay (IGRA)
G_TB_Test_Result: Negative

G_CD_Diagnosed: Yes
G_Prescribed_by_GI: Yes
G_Initiation_IV_Loading: Yes
G_Currently_Receiving: No
G_Loading_Dose_Weeks: 0, 4, 8
G_Maintenance_Dose: 360 mg SQ at week 12 and every 8 weeks

Acknowledgement_Request_Completed_By: Timothy Adam, MD
Acknowledgement_Date: 05/30/2023
```